Agreed. Investors or all type have to want to buy the shares.
We need to give the market what it wants. And if that means fresh blood, then that has to happen as well. The wages paid are not entry level yet the current group act like they are in training.
- Forums
- ASX - By Stock
- Ann: Meeting Requested with FDA on Revascor Accelerated Approval
MSB
mesoblast limited
Add to My Watchlist
1.92%
!
$1.79

Agreed. Investors or all type have to want to buy the shares. We...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.79 |
Change
-0.035(1.92%) |
Mkt cap ! $2.287B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $11.91M | 6.671M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 44994 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 28695 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 44994 | 1.790 |
1 | 53149 | 1.785 |
6 | 82839 | 1.780 |
1 | 17489 | 1.775 |
4 | 82576 | 1.770 |
Price($) | Vol. | No. |
---|---|---|
1.800 | 28695 | 2 |
1.805 | 6652 | 2 |
1.810 | 66208 | 7 |
1.815 | 59694 | 4 |
1.820 | 25818 | 3 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online